CareLit Fachartikel

Striatal Hypertrophy: A Mechanism for Preclinical Compensation in Parkin-Associated Parkinsonism?

F Binkofski, HR Siebner, C Buhmann, P Pramstaller, K Hedrich, T van Eimeren, C Büchel, C Klein, C Gaser · Klinische Neurophysiologie · 2004 · Heft 08

Dokument
909143
CareLit-ID
Jahr
2004
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Klinische Neurophysiologie
Autor:innen
F Binkofski, HR Siebner, C Buhmann, P Pramstaller, K Hedrich, T van Eimeren, C Büchel, C Klein, C Gaser
Ausgabe
Heft 08 / 2004
Seiten
–
Erschienen: 2004-08-25 00:00:00
ISSN
1434-0275

Zusammenfassung

18F-Fluorodopa (F-DOPA) positron emission tomography (PET) demonstrated a reduction of striatal F-DOPA uptake in asymptomatic carriers of heterozygous Parkin mutations, indicating a latent dopaminergic dysfunction in the basal ganglia. We used voxel-based morphometry of high-resolution structural magnetic resonance images in a comparable group of asymptomatic Parkin mutation carriers to investigate whether this latent dopaminergic dysfunction is associated with structural abnormalities in the motor system. Structural MR data (T1-weighted FLASH 3D MR sequences; TE=5 ms; TR=15 ms; flip angle=30°; isotropic voxel s…

Schlagworte

Klinische Neurophysiologie